{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444308733
| IUPAC_name = (3''Z'')-3-[(''Z'')-(17-Hydroxy-2,10,13,17-tetramethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1''H''-cyclopenta[''a'']phenanthren-3-ylidene)hydrazinylidene]-2,10,13,17-tetramethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1''H''-cyclopenta[''a'']phenanthren-17-ol
| image = Mebolazine.png
| width = 250

<!--Clinical data-->
| tradename = Dostalon, Roxilon
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3625-07-8
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| ATC_supplemental = 
| PubChem = 9571069
| IUPHAR_ligand = 
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 16736946
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 69C642I19V
| KEGG = 
| ChEBI = 
| ChEMBL = 

<!--Chemical data-->
| C=42 | H=68 | N=2 | O=2
| SMILES = C[C@@]23[C@](CC[C@]4([H])[C@@]([H])3CC[C@@]5(C)[C@]([H])4CC[C@@](C)5O)([H])C/C([C@H](C)C2)=N/N=C1[C@H](C)C[C@@]6(C)[C@](CC[C@]7([H])[C@@]([H])6CC[C@@]8(C)[C@]([H])7CC[C@@](C)8O)([H])C/1
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C42H68N2O2/c1-25-23-37(3)27(9-11-29-31(37)13-17-39(5)33(29)15-19-41(39,7)45)21-35(25)43-44-36-22-28-10-12-30-32(38(28,4)24-26(36)2)14-18-40(6)34(30)16-20-42(40,8)46/h25-34,45-46H,9-24H2,1-8H3/b43-35-,44-36-/t25-,26-,27+,28+,29-,30-,31+,32+,33+,34+,37+,38+,39+,40+,41+,42+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = POPWFGNRCCUJGU-QQZDHCPGSA-N
| synonyms = Dimethazine, Dymethazine; Dimethasterone azine; Di(methasterone) azine; 2α,17α-Dimethyl-5α-androstan-17β-ol-3-one azine
}}

'''Mebolazine''' ([[International Nonproprietary Name|INN]]; brand names '''Dostalon''' and '''Roxilon'''; also known as '''dimethazine''', '''dymethazine''', '''di(methasterone) azine''', or '''2α,17α-dimethyl-5α-androstan-17β-ol-3-one azine''') is a [[synthetic compound|synthetic]], [[oral administration|orally active]] [[anabolic-androgenic steroid]] (AAS) and a [[17α-alkylated anabolic steroid|17α-alkylated]] [[chemical derivative|derivative]] of [[dihydrotestosterone]] (DHT) that is no longer marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA756|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=756–}}</ref><ref name="pmid26663462">{{cite journal | vauthors = Geldof L, Tudela E, Lootens L, van Lysebeth J, Meuleman P, Leroux-Roels G, van Eenoo P, Deventer K | title = In vitro and in vivo metabolism studies of dimethazine | journal = Biomed. Chromatogr. | volume = 30 | issue = 8 | pages = 1202–9 | year = 2016 | pmid = 26663462 | doi = 10.1002/bmc.3668 | url = }}</ref> It has a unique and unusual [[chemical structure]], being a [[dimer (chemistry)|dimer]] of [[methasterone]] linked at the 3-position of the A-[[ring (chemistry)|ring]] by an [[azine]] [[functional group|group]], and reportedly acts as a [[prodrug]] of methasterone.<ref name="ClemensPressman2015">{{cite journal|last1=Clemens|first1=Roger|work=Preventive Nutrition | title = Nutritional and Dietary Supplements: Code or Concern|last2=Pressman|first2=Peter|year=2015|pages=47–62|doi=10.1007/978-3-319-22431-2_3 |isbn=978-3-319-22430-5 }}</ref>

Since 2008, mebolazine has been used illegally as an ingredient is some dietary supplements,<ref>{{Cite journal | doi = 10.1111/andr.307| pmid = 25684733| title = Designer steroids - over-the-counter supplements and their androgenic component: Review of an increasing problem| journal = Andrology| volume = 3| issue = 2| pages = 150| year = 2015| last1 = Rahnema| first1 = C. D.| last2 = Crosnoe| first2 = L. E.| last3 = Kim| first3 = E. D.}}</ref> including [[vitamin B]] supplements, and in the United States the [[Food and Drug Administration]] has taken legal action against such manufacturers.<ref>See, for example: {{Cite web | title =  FDA Warns Consumers About Health Risks With Healthy Life Chemistry Dietary Supplement | url = http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm362799.htm | publisher = [[Food and Drug Administration]]}}</ref><ref>{{cite web | title = Criminal Investigations (2011) Dietary Supplements Manufacturer Sentenced | url = http://www.fda.gov/ICECI/CriminalInvestigations/ucm254526.htm | publisher = Department of Justice}}</ref>

==See also==
* [[Bolazine]]

==References==
{{Reflist|2}}


{{Androgens and antiandrogens}}
{{Androgen receptor modulators}}

[[Category:Androgens and anabolic steroids]]
[[Category:Androstanes]]
[[Category:Nitrogen compounds]]
[[Category:Dimers (chemistry)]]
[[Category:Hepatotoxins]]
[[Category:Prodrugs]]
[[Category:Withdrawn drugs]]